Evidence map›Paper›PMID 25429256›Full record

ArticleFrontiers in neuroscience2014

An evaluation of progressive amyloidogenic and pro-inflammatory change in the primary visual cortex and retina in Alzheimer's disease (AD).

James M Hill, Prerna Dua, Christian Clement, Walter J Lukiw

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in neuroscience, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

James M HillLouisiana State University Neuroscience Center and Departments of Ophthalmology and Pharmacology, Louisiana State University Health Science Center New Orleans, LA, USA.
Prerna DuaDepartment of Health Information Management, Louisiana State University Ruston, LA, USA.
Christian ClementDepartment of Natural Sciences, Infectious Diseases, Experimental Therapeutics and Human Toxicology Lab, Southern University at New Orleans New Orleans, LA, USA.
Walter J LukiwLouisiana State University Neuroscience Center and Departments of Ophthalmology and Pharmacology, Louisiana State University Health Science Center New Orleans, LA, USA ; Department of Neurology, Louisiana State University Health Science Center New Orleans, LA, USA.

Funding

OCULAR HSV: LATENCY, REACTIVATION, &RECURRENCER01EY006311 · NEI · LSU HEALTH SCIENCES CENTER · PI LUKIW, WALTER J · 1985 to 2012
$5.3M
microRNA (miRNA) signaling in Alzheimer's disease(AD)R01AG038834 · NIA · LSU HEALTH SCIENCES CENTER · PI BAZAN, NICOLAS G. · 2011 to 2020
$3.3M
NEI NIH HHS R01 EY006311NIA NIH HHS R01 AG038834
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Alzheimer's disease (AD)amyloidAβ42 peptidesinflammatory signalingretinaspreadingvisual system

Identifiers

PMID25429256
PMCPMC4228830

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.